Abstract:Microencapsulation is a promising strategy to prolong the survival and function of transplanted pancreatic islets for diabetes therapy, albeit its translation has been impeded by incoherent graft performance. The use of decellularized ECM has lately gained substantial research momentum due to its innate capacity to augment the function of cells originating from the same tissue type. In the present study, the advantages of both these approaches are leveraged in a porcine pancreatic ECM (pECM)-based microencapsulation platform, thus significantly enhancing murine pancreatic islet performance. pECM-encapsulated islets sustain high insulin secretion levels in vitro, surpassing those of islets encapsulated in conventional alginate microcapsules. Moreover, pECM-encapsulated islet cells proliferate and produce an enriched intra-islet ECM framework, displaying a distinctive structural rearrangement. The beneficial effect of pECM encapsulation is further reinforced by the temporary protection against cytokine-induced cytotoxicity. In-vivo, this platform significantly improves glucose tolerance and achieves glycemic correction in 100% of immunocompetent diabetic mice without any immunosuppression, compared to only 50% mice achieved glycemic correction by alginate encapsulation. Altogether, the results presented herein reveal that pECM-based microencapsulation offers a natural pancreatic niche that can restore the function of isolated pancreatic islets and deliver them safely, avoiding the need for immunosuppression. STATEMENT OF SIGNIFICANCE: Aiming to improve pancreatic islet transplantation outcomes in diabetic patients, we developed a microencapsulation platform based on pancreatic extracellular matrix (pECM). In these microcapsules the islets are entrapped within a pECM hydrogel that mimics the natural pancreatic microenvironment. We show that pECM encapsulation supports the islets' viability and function in culture, and provides temporal protection against cytokine-induced stress. In a diabetic mouse model, pECM encapsulation significantly improved glucose tolerance and achieved glycemic correction without any immunosuppression. These results reveal the potential of pECM encapsulation as a viable treatment for diabetes, providing a solid scientific basis for more advanced preclinical studies.

Unlocking the Promise of Decellularized Pancreatic Tissue: A Novel Approach to Support Angiogenesis in Engineered Tissue

Using GRGDSPC peptides to improve re-endothelialization of decellularized pancreatic scaffolds

Decellularized human pancreatic extracellular matrix-based physiomimetic microenvironment for human islet culture

Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas

Detergent-Free Decellularization of the Human Pancreas for Soluble Extracellular Matrix (ECM) Production

Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application

Construction of engineered 3D islet micro-tissue using porcine decellularized ECM for the treatment of diabetes

The Research of Acellular Pancreatic Bioscaffoldas a Natural 3D Platform in Vitro

Highly Efficient Local Delivery of Endothelial Progenitor Cells Significantly Potentiates Angiogenesis and Full-Thickness Wound Healing.

Extracellular Matrix Mimicking Nanofibrous Scaffolds Modified With Mesenchymal Stem Cell-Derived Extracellular Vesicles for Improved Vascularization

ECM-based bioactive microencapsulation significantly improves islet function and graft performance

Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing.

Prevascularization of Natural Nanofibrous Extracellular Matrix for Engineering Completely Biological Three-Dimensional Prevascularized Tissues for Diverse Applications

Engineering of Highly Interconnected Inverse Opal Extracellular Matrix Scaffolds for Enhanced Cell Transplantation and Vascularization of Ischemic Tissue

Evaluating the Biocompatibility of Decellularized Pancreas and Its Histological Features as a Support Structure for Adipose Mesenchymal Stem Cell Culture

Generation of a pancreas derived hydrogel for the culture of hiPSC derived pancreatic endocrine cells

The Higher Inherent Therapeutic Potential of Biomaterial-Based Hdpscs and Henscs for Pancreas Diseases

Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering

The Research of Acellular Pancreatic Bioscaffold As a Natural 3-Dimensional Platform in Vitro

Comparative decellularization and recellularization of normal versus Streptozotocin-induced diabetes mellitus rat pancreas.

Engineered nanovesicles from stromal vascular fraction promote angiogenesis and adipogenesis inside decellularized adipose tissue through encapsulating growth factors